Zoetis/ZTS

$146.50

-4.31%
-
1D1W1MYTD1YMAX

About Zoetis

Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. It has a diversified business, commercializing products across eight core species: dogs, cats and horses (companion animals) and cattle, swine, poultry, fish and sheep (livestock); and within seven major product categories: parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics and medicated feed additives. The Company operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.

Ticker

ZTS

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Kristin Peck

Employees

14,100

Headquarters

Parsippany, United States

Zoetis Metrics

BasicAdvanced
$69.96B
Market cap
30.20
P/E ratio
$5.07
EPS
0.87
Beta
$1.50
Dividend rate
1.13%
Dividend yield
$69.96B
0.86791
$201.92
$148.48
3.21M
$1.50
3.358
2.001
131.359
131.419
30.55%
52.939
17.15%
16.02%
49.86%
19.37%
30.196
8.189
14.045
77.737
75.31
0.59%
0.98%
1.13%
5.74%
12.81%
8.58%
14%
23.31%

What the Analysts think about Zoetis

Analyst Ratings

Majority rating from 18 analysts.
Buy

Price Targets

Average projection from 14 analysts.
51.33% upside
High $260.00
Low $187.00
$146.50
Current price
$221.70
Average price target

Zoetis Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
23.72% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$2.21B
2.88%
Net income
$525M
-11.91%
Profit margin
23.72%
-14.37%

Zoetis Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 6.01%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.31
$1.41
$1.36
$1.24
-
Expected
$1.26
$1.32
$1.36
$1.32
$1.35
Surprise
3.89%
7.19%
0.08%
-6.01%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Zoetis stock?

Zoetis (ZTS) has a market cap of $69.96B as of April 20, 2024.

What is the P/E ratio for Zoetis stock?

The price to earnings (P/E) ratio for Zoetis (ZTS) stock is 30.2 as of April 20, 2024.

Does Zoetis stock pay dividends?

Yes, the Zoetis (ZTS) stock pays dividends to shareholders. As of April 20, 2024, the dividend rate is $1.5 and the yield is 1.13%. Zoetis has a payout ratio of 30.55% on a trailing twelve-month basis.

When is the next Zoetis dividend payment date?

The next Zoetis (ZTS) dividend payment is scheduled for June 04, 2024.

What is the beta indicator for Zoetis?

Zoetis (ZTS) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Zoetis stock price target?

The target price for Zoetis (ZTS) stock is $221.7, which is 51.33% above the current price of $146.5. This is an average based on projections from 14 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Zoetis stock

Buy or sell Zoetis stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing